Technical Analysis for MRK - Merck & Company, Inc.

Grade Last Price % Change Price Change
grade A 72.35 0.19% 0.14
MRK closed up 0.19 percent on Friday, October 19, 2018, on 1.67 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Oct 25

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical MRK trend table...

Date Alert Name Type % Chg
Oct 19 MACD Bullish Signal Line Cross Bullish 0.00%
Oct 19 New 52 Week Closing High Bullish 0.00%
Oct 19 Pocket Pivot Bullish Swing Setup 0.00%
Oct 19 NR7 Range Contraction 0.00%
Oct 19 NR7-2 Range Contraction 0.00%
Oct 19 Doji - Bearish? Reversal 0.00%
Oct 19 Stochastic Reached Overbought Strength 0.00%
Oct 19 Overbought Stochastic Strength 0.00%
Oct 19 Up 3 Days in a Row Strength 0.00%
Oct 19 Up 4 Days in a Row Strength 0.00%

Older signals for MRK ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, and others. The company also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. In addition, it discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. Further, the company manufactures and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and products for occasional constipation and frequent heartburn. Additionally, it offers foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has a collaboration with Sanofi Pasteur S.A. and Abide Therapeutics, Inc.; and has a collaboration and license agreement with Luminex Corporation. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Is MRK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 72.89
52 Week Low 52.6595
Average Volume 8,154,034
200-Day Moving Average 61.5851
50-Day Moving Average 69.8384
20-Day Moving Average 70.9905
10-Day Moving Average 70.949
Average True Range 1.2155
ADX 29.92
+DI 25.3611
-DI 16.8007
Chandelier Exit (Long, 3 ATRs ) 69.2435
Chandelier Exit (Short, 3 ATRs ) 71.4665
Upper Bollinger Band 72.9271
Lower Bollinger Band 69.0539
Percent B (%b) 0.85
BandWidth 5.455941
MACD Line 0.5144
MACD Signal Line 0.4678
MACD Histogram 0.0466
Fundamentals Value
Market Cap 197.32 Billion
Num Shares 2.73 Billion
EPS 1.85
Price-to-Earnings (P/E) Ratio 39.11
Price-to-Sales 4.23
Price-to-Book 4.28
PEG Ratio 2.67
Dividend 1.88
Dividend Yield 2.60%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 73.43
Resistance 3 (R3) 73.41 73.03 73.25
Resistance 2 (R2) 73.03 72.75 73.04 73.19
Resistance 1 (R1) 72.69 72.59 72.86 72.71 73.13
Pivot Point 72.31 72.31 72.40 72.32 72.31
Support 1 (S1) 71.97 72.03 72.14 71.99 71.57
Support 2 (S2) 71.59 71.87 71.60 71.51
Support 3 (S3) 71.25 71.59 71.45
Support 4 (S4) 71.27